Status:

COMPLETED

Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome

Lead Sponsor:

Laboratoires Thea

Conditions:

Dry Eye Syndromes

Eligibility:

All Genders

18-90 years

Phase:

PHASE2

Brief Summary

To evaluate the efficacy of a 6-month (± 14 days) dietary supplementation period with T1675, a per os omega 3 and omega 6 polyunsaturated essential fatty acid dietary formulation, versus placebo in pa...

Detailed Description

The aim of the present study is to evaluate the efficacy of a 6-month (± 14 days) dietary supplementation period with T1675 versus placebo in patients with bilateral moderate dry eye syndrome already ...

Eligibility Criteria

Inclusion

  • Signed and dated informed consent.
  • Male or female aged from 18 to 90 years old.
  • Known treated bilateral dry eye.
  • Dry eye syndrome confirmed by ocular examination with a fluorescein and/or lissamine green staining, BUT and Schirmer, performed within the last 12 months before Inclusion Visit, for both eyes.
  • Bilateral symptomatology suggestive of dry eye defined by: at least one of the following ocular symptoms suggestive of dry eye (burning, stinging, dryness feeling, sandy and/or gritty sensation, light sensitivity, reflex tearing, ocular fatigue) and Questioning on patient's feeling (score \>=3).
  • Fulfilling the following criteria of dry eye syndrome in both eyes defined by: Keratoconjunctivitis defined by a lissamine green score ≥ 4 (Van Bijsterveld score) and Schirmer test \<= 10 mm in 5 min or BUT \< 10 s

Exclusion

  • severe dry eye symptom
  • eyelid dysfunction
  • severe progressive rosacea
  • any relevant ocular anomaly interfering with ocular surface
  • best corrected far visual acuity \<= 1/10
  • history of ocular allergy
  • traumatism, infection, inflammation within last 3 months
  • ocular surgery and laser within the last 3 months
  • lasik, laser, PKR within the last 12 months
  • contact lenses
  • any concomitant nutritive supplementation, vitamins
  • any topical concomitant treatment

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

End Date :

May 1 2005

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00357201

Start Date

November 1 2004

End Date

May 1 2005

Last Update

July 27 2006

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.